Talia Diker Cohen (Talia Diker-Cohen, T Diker-Cohen)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Systematic Review

Postmenopausal Women

Top Venues

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Internal and emergency medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
D Rosenberg, T Avni, G Tsvetov, A Gafter-Gvili, Talia Diker Cohen
Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 32 (3) (2020)
Gloria Tsvetov, O Amitai, Talia Diker Cohen
Response to letter to the editor OSIN-D-20-00441 re: "Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?" Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 31 (8) (2020)
Gloria Tsvetov, O Amitai, T Shochat, I Shimon, A Akirov, Talia Diker Cohen
Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low? Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 31 (4) (2019)
Talia Diker Cohen, Benaya Rozen-Zvi, Dana Yelin, Amit Akirov, Eyal Robenshtok, Anat Gafter-Gvili, Daniel Shepshelovich
Endocrinopathy-induced euvolemic hyponatremia. Internal and emergency medicine 13 (5) (2018)